Videos

Experts on chronic lymphocytic leukemia discuss how to approach cost considerations and available resources for CLL treatments.

Insights on supportive care and approaches to managing adverse effects of BTK inhibitors in the treatment of chronic lymphocytic leukemia.

Mayra Andujar Delgado does not shy away from discussing her myelofibrosis diagnosis. In fact, the survivor becomes empowered by sharing her knowledge with others.

Jessica Kuhns, a patient living with a myeloproliferative neoplasm, makes it a point to ensure she can understand what doctors are telling her, so that she can take that knowledge and tell other people.

CLL expert Lori A. Leslie, MD, gives a comprehensive overview of the ALPINE and ELEVATE-RR head-to-head studies of BTK inhibitors in CLL.

Lori A. Leslie, MD, an expert on CLL, talks about factors that influence treatment decisions.

After the COVID-19 pandemic broadened usage of telehealth, patients with myeloma now have more access to experts in their disease.

CLL experts offer insights on shared decision-making with patients while selecting treatments.

Lori A. Leslie, MD, an expert on chronic lymphocytic leukemia, provides a comprehensive overview of BTK inhibitors used in the treatment of CLL.

There are certain side effects from Elahere — a newly approved ovarian cancer drug — that patients taking the treatment should look out for, an expert said.

Hoshiyuki Iida, APN, discusses his role in the multidisciplinary team in the treatment of patients with chronic lymphocytic leukemia.

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process.

Watch Dr. Rupesh Kotecha, from Miami Cancer Institute, Baptist Health South Florida, discuss the treatment of brain metastases during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Ana C. Sandoval Leon, from Miami Cancer Institute, Baptist Health South Florida, discuss HER2-positive metastatic disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

In this Educated Patient® webinar, CURE® spoke with experts from Allegheny Health Network about addressing disparities in diversity, equity and inclusion in cancer care.

Watch Dr. Naomi Dempsey, from Miami Cancer Institute, discuss the management of HER2-positive, early-stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Antibody drug conjugates, which are used to treat various types of cancer, can cause eye issues, though they are easily treated if caught early, one expert said.

Watch Dr. Patrick Borgen, from Maimonides Medical Center, discuss the de-escalation of surgery during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Joseph Panoff, from Miami Cancer Institute, Baptist Health South Florida, discuss radiation therapy in early stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Patients with ovarian cancer who utilized palliative care tended to have fewer hospital readmissions than those who did not, according to a recent study.

Watch Dr. Susan Domchek, Dr. Debu Tripathy and Dr. Jennifer Gass answer questions about precision medicine during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Debu Tripathy, from The University of Texas MD Anderson Cancer Center, discuss circulating tumor DNA during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Susan Domchek, from Penn Medicine, discuss genetic testing during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. William J Gradishar, Dr. Kevin Kalinsky and Kelly Thomas answer questions about hormone receptor-positive and triple-negative breast cancer treatment options during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Patients with HER2-positive breast cancer often need to undergo aggressive treatment, but ongoing research is determining if chemotherapy can be scaled back for certain patients.

Watch Dr. Kevin Kalisnky, from Winship Cancer Institute of Emory University, discuss treatment for triple-negative disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. William J. Gradishar, from Northwestern University, discuss the management of hormone receptor-positive disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Isabel Octaviano, from Miami Cancer Institute, Baptist Health South Florida, discuss the nursing perspective to clinical trials during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Reshma Mahtani, from Miami Cancer Institute, Baptist Health South Florida, discuss clinical trial myths during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Anne O'Dea, from University of Kansas Medical Center, discuss targeting ESR1 mutations during the CURE Educated Patient® Breast Cancer Summit at MBCC.